| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 4.243 | 7.396 | 6.992 | 8.610 | 12.249 | 15.042 | 20.691 | 27.211 | 69.737 |
| Total Income - EUR | - | 4.243 | 7.396 | 6.992 | 8.610 | 12.249 | 15.042 | 20.692 | 27.212 | 69.737 |
| Total Expenses - EUR | - | 115 | 115 | 442 | 405 | 367 | 428 | 547 | 8.194 | 9.301 |
| Gross Profit/Loss - EUR | - | 4.128 | 7.281 | 6.550 | 8.205 | 11.881 | 14.614 | 20.146 | 19.018 | 60.436 |
| Net Profit/Loss - EUR | - | 4.000 | 7.059 | 6.338 | 7.987 | 11.563 | 14.172 | 19.630 | 18.751 | 58.386 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Danrad Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 4.142 | 11.184 | 6.430 | 14.317 | 20.127 | 15.380 | 36.282 | 21.409 | 65.361 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 2.610 | 10.375 | 1.457 | 1.429 | 1.431 | 439 | 16.714 | 21.266 | 49.891 |
| Cash | - | 1.532 | 810 | 4.974 | 12.888 | 18.696 | 14.941 | 19.568 | 144 | 15.470 |
| Shareholders Funds | - | 4.045 | 11.035 | 6.390 | 14.253 | 20.026 | 14.231 | 19.678 | 18.800 | 58.434 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 127 | 149 | 40 | 64 | 101 | 1.150 | 16.604 | 2.609 | 6.927 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Danrad Med Srl